"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

Laine Mello, director of marketing at Ecolab Bioprocessing, reflects on how the use of digital technologies expanded in the ...

The Union Health Ministry is in talks with states about extending the deadline for pharmaceutical companies to meet new ...

Chief among the factors driving a sense of optimism among the biopharma leaders was the unfreezing of the biotech investing ...

Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...

Singapore’s industrial production growth averaged 8.2 per cent in the first 11 months of 2025. This was partly due to ...

Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

The reforms have helped improve the domestic healthcare system by enabling pharma firms to overcome a medicine shortage ...

Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...

According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation.